NEPHROS INC·4

Dec 18, 5:27 PM ET

Spandow Oliver J. 4

4 · NEPHROS INC · Filed Dec 18, 2018

Insider Transaction Report

Form 4
Period: 2018-12-14
Transactions
  • Award

    Common Stock

    2018-12-14+18,03088,080 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.62Exp: 2028-08-10Common Stock (85,199 underlying)
    85,199
Footnotes (2)
  • [F1]On December 14, 2018, the Company granted 18,030 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Spandow in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]The option vests as to 28,400 shares on each of 8/10/19 and 8/10/20 and as to 28,399 shares on 8/10/21.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT